This is an inflection point and key to FDA approval and commercialization which is what SI will be discussing TODAY at the ISSCR.
Volume will go through the roof today!
- Forums
- ASX - By Stock
- MSB
- Ann: Key Day 100 Survival Results In P3 GvHD Trial
MSB
mesoblast limited
Add to My Watchlist
1.08%
!
$2.34

Ann: Key Day 100 Survival Results In P3 GvHD Trial, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.34 |
Change
0.025(1.08%) |
Mkt cap ! $2.988B |
Open | High | Low | Value | Volume |
$2.32 | $2.39 | $2.27 | $4.112M | 1.763M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
35 | 110350 | $2.33 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.34 | 14904 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
34 | 103420 | 2.330 |
20 | 61379 | 2.320 |
16 | 114714 | 2.310 |
17 | 143326 | 2.300 |
12 | 258664 | 2.290 |
Price($) | Vol. | No. |
---|---|---|
2.340 | 17840 | 9 |
2.350 | 31223 | 20 |
2.360 | 78313 | 19 |
2.370 | 64303 | 13 |
2.380 | 92463 | 10 |
Last trade - 10.49am 22/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |